gabapentin

Generic: gabapentin

Labeler: asclemed usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name gabapentin
Generic Name gabapentin
Labeler asclemed usa, inc.
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

gabapentin 300 mg/1

Manufacturer
Asclemed USA, Inc.

Identifiers & Regulatory

Product NDC 76420-020
Product ID 76420-020_a7b785f9-4f75-92ed-e053-2995a90a9fa5
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090705
Listing Expiration 2026-12-31
Marketing Start 2017-12-05

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76420020
Hyphenated Format 76420-020

Supplemental Identifiers

RxCUI
310431
UNII
6CW7F3G59X
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name gabapentin (source: ndc)
Generic Name gabapentin (source: ndc)
Application Number ANDA090705 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 300 mg/1
source: ndc
Packaging
  • 240 CAPSULE in 1 BOTTLE (76420-020-24)
  • 30 CAPSULE in 1 BOTTLE (76420-020-30)
  • 60 CAPSULE in 1 BOTTLE (76420-020-60)
  • 90 CAPSULE in 1 BOTTLE (76420-020-90)
source: ndc

Packages (4)

76420-020-24 240 CAPSULE in 1 BOTTLE (76420-020-24) 76420-020-30 30 CAPSULE in 1 BOTTLE (76420-020-30) 76420-020-60 60 CAPSULE in 1 BOTTLE (76420-020-60) 76420-020-90 90 CAPSULE in 1 BOTTLE (76420-020-90)

Ingredients (1)

gabapentin (300 mg/1)

Linked Drug Pages (1)

GABAPENTIN ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "a7b785f9-4f75-92ed-e053-2995a90a9fa5", "openfda": {"nui": ["N0000008486"], "unii": ["6CW7F3G59X"], "rxcui": ["310431"], "spl_set_id": ["45039bba-7a96-450c-95be-83a3aa4fcbd2"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Asclemed USA, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "240 CAPSULE in 1 BOTTLE (76420-020-24)", "package_ndc": "76420-020-24", "marketing_start_date": "20200610"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (76420-020-30)", "package_ndc": "76420-020-30", "marketing_start_date": "20200610"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE (76420-020-60)", "package_ndc": "76420-020-60", "marketing_start_date": "20200610"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE (76420-020-90)", "package_ndc": "76420-020-90", "marketing_start_date": "20200610"}], "brand_name": "GABAPENTIN", "product_id": "76420-020_a7b785f9-4f75-92ed-e053-2995a90a9fa5", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "76420-020", "generic_name": "GABAPENTIN", "labeler_name": "Asclemed USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GABAPENTIN", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090705", "marketing_category": "ANDA", "marketing_start_date": "20171205", "listing_expiration_date": "20261231"}